PharmaCrunch

Why there is an increasing demand for Cancer medicines?

In an article published by EvaluatePharma® World Preview 2015, Outlook to 2020, it reflected that most of the companies are pumping their money in R&D of oncology, anti-rheumatic & anti-diabetic drugs.

Therapy AreasOncology being number – 1 therapy area with the fastest momentum in growth & largest market share in terms of value, making it most preferred choice to invest. Oncology which requires extremely niche therapy insights is expected to grow by more than 11% plus & has been forecasted to break all the previous records.

But why Oncology became a choice of investment for pharmaceutical companies & what forced them to develop an expertise in this segment.

The answer to this questions underlies on the growing incidences of Cancer diseases globally. Cancer has grown in all its forms, be in breast, colorectal, cervical or lung.

Let’s see some statistics from recent WHO report:

According to the International Agency for Research on Cancer (IARC), an estimated 14.1 million new cases of cancer occur with mortality of 8.2 million worldwide. There are more than 100 types of cancer. Let’s see some eye-opening statistics of high mortality forms of cancer.

Lung Cancer: 

  1. As per WHO 1.8 million new cases of lung cancer in 2012 and 1.59 million estimated deaths globally.

  2. As reported by the American Cancer Society, the estimated new cases of lung cancer in 2017 would be around 222,500 and the estimated mortality would be around 155,870 in the US alone.

  3. There are approximately 52 drugs approved for the treatment of Non-Small Cell Lung Cancer, showing an increased effort towards treating lung cancer.

Breast Cancer: 

  1. As per WHO there were estimated 1.67 million new cases in 2012 and 522,000 million estimated deaths globally.

  2. As reported by the American Cancer Society, the estimated new cases of invasive breast cancer and in situ breast cancer in 2017 would be around 252,710 and 63,410 respectively

  3. The estimated mortality would be around 40,610 in the US alone.

  4. There are approximately 63 drugs approved for the treatment of breast cancer, and a vast pipeline aiming to decrease the mortality associated with this type.

Colorectal Cancer:

  1. Around 1.36 million new cases of colorectal cancer in 2012 and 694,000 estimated deaths.

  2. As reported by the American Cancer Society, the estimated new cases in 2014 were around 136,830 and the estimated mortality was around 50,310 in the US alone.

Prostate Cancer: 

  1. Prostate Cancer has also become a concern in terms of mortality and morbidity, with WHO reporting that globally there would be estimated 1.09 million new cases of prostate cancer in 2012 and 307,000 estimated deaths.

  2. The American Cancer Society also estimates new cases of colorectal cancer in 2017 to be around 161,360 and the estimated mortality to be around 26,730 in the US alone.

  3. There are approximately 28 drugs approved for the treatment of prostate cancer, showing immense R&D interest.

0 responses on "Why there is an increasing demand for Cancer medicines?"

Leave a Message

Your email address will not be published. Required fields are marked *

FREE PHARMA NEWSLETTER VIA EMAIL

Join fastest growing subscribers who benefit from PharmaCrunch’s coverage on "Pharmaceuticals - Must to Know" updates

Testimonial from Subscribers

Read more

Nirbhay Patel

Business Manager - Sanofi India
top
2016 © PharmaCrunch All rights reserved
Skip to toolbar